In the United States between 2017 and 2018 adults aged 20 and above had a prevalence of obesity of 42.4% and a prevalence of severe obesity of 9.2% (206)
Bcl-2: B-cell lymphoma 2, Bcl-XL: B-cell lymphoma-extra large, cAMP: cyclic adenosine monophosphate, CREB: cAMP-response element-binding protein, FoxO1/O3: forkhead box transcription factor 1/3, GLP1R: glucagon-like peptide-1 receptor, GSK-3: glycogen synthase kinase-3, LTP: long-term potentiation, MAPK: mitogen-activated protein kinase, mTOR: mammalian target of rapamycin, NF-B: nuclear factor kappa B, PD: Parkinsons disease, PI3K: phosphoinositide 3-kinase, PKA: protein kinase A
These findings suggest that GLP-1 therapies may target both reward-seeking and stress-driven addiction behaviors, but the review emphasized that stress-system effects are complex and not yet fully understood
A smaller subset of users notice localized reactions at injection sites beyond typical injection-site sorenesssuch as delayed itching or mild dermatitis lasting several hours after administration
Research also suggests its potential for managing inflammatory bowel disease due to its potent anti-inflammatory properties
CULES SON LOS BENEFICIOS DE SU SUPLEMENTACIN
